Gold bars to be exempt from tariffs, White House clarifies
Director Rebecca B. Robertson of Ceribell, Inc. (CBLL), a medical technology company currently valued at $643 million, recently sold 18,633 shares of common stock for approximately $330,961. According to InvestingPro analysis, the company maintains impressive gross profit margins of 87% and holds more cash than debt on its balance sheet.
The sales occurred in two separate transactions. On June 17, 2025, Robertson sold 7,445 shares in multiple transactions at prices ranging from $17.01 to $17.90. On June 18, 2025, Robertson sold 11,188 shares in multiple transactions at prices ranging from $17.80 to $17.96. With analyst price targets ranging from $26 to $36, InvestingPro data suggests the stock is currently trading below Fair Value.
Following these transactions, Robertson directly owns 10,042 shares of Ceribell, Inc. (CBLL).
The sales were executed under a pre-arranged Rule 10b5-1 trading plan.
In other recent news, Ceribell Inc. reported a notable 42% increase in first-quarter 2025 revenue, reaching $20.5 million, despite facing a net loss of $12.8 million. The company raised its full-year revenue guidance to between $83 million and $87 million, reflecting management’s confidence in sustained growth. In addition, Ceribell received FDA clearance for a new pediatric seizure detection algorithm, expanding its market reach. At their 2025 Annual Meeting of Stockholders, Ceribell’s shareholders elected Juliet Tammenoms Bakker and Lucian Iancovici, M.D. as directors and ratified PricewaterhouseCoopers LLP as the company’s auditor for the fiscal year 2025. TD Cowen maintained a Buy rating on Ceribell, with a $36.00 price target, citing potential benefits from easing US-China trade tensions. The firm noted that Ceribell’s financial health remains strong despite tariff challenges, and any positive developments in trade discussions could improve the company’s margins. Investors are closely monitoring these developments, as they could significantly impact Ceribell’s cost structure and profitability.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.